# IP Group

> IP Group is a VC fund in London backing Health Care and Biotechnology. See 206 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 206
- Last investment: Jul 2026
- Lead investor: 21%
- Fund size: $125M
- Last fund: Jan 2014
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/ip-group-plc
- X (Twitter): http://twitter.com/IPGroupplc
- Website: http://www.ipgroupplc.com

IP Group is a VC fund in London focused on Health Care and Biotechnology. IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

## Contacts

5 contacts available for IP Group. Shizune tracks 23 team members at IP Group. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ip-group-plc?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $393k–$8.5M |
| Series A | $2.4M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 30 | 15% |
| Biotechnology | 28 | 14% |
| Therapeutics | 16 | 8% |
| Information Technology | 16 | 8% |
| Software | 13 | 6% |

124 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 38 | 18% |
| Series A | 33 | 16% |
| Funding Round | 28 | 14% |
| Series B | 27 | 13% |
| Series C | 12 | 6% |

14 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 79 | 38% |
| United States | 13 | 6% |
| Australia | 4 | 2% |
| New Zealand | 2 | 1% |
| France | 1 | 0% |

8 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ben Murphey | Investment Director | 2 | https://shizune.co/investors/profile/ben-murphey-ea6e |
| Dani Bach | Partner, Life Sciences | 3 | https://shizune.co/investors/profile/dani-bach |
| Greg Smith | Chief Financial Officer | 0 | https://shizune.co/investors/profile/greg-smith-3 |
| Jamie Vollbracht | Partner, Cleantech | 3 | https://shizune.co/investors/profile/jamie-vollbracht |
| Manjari Chandran-Ramesh | Investment Director | 7 | https://shizune.co/investors/profile/manjari-chandran-ramesh |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mach42 | Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity. | $9.4M | Seed | Jul 21, 2026 |  |
| MAKO | Solving human problems with nature’s surfaces. | $19.3M | Series A | Jun 29, 2026 |  |
| Slamcore | SLAMcore’s mission is to make commercial-grade spatial intelligence accessible to allTheir team of world-leading spatial intelligence experts have developed advanced SLAM (simultaneous localization and mapping) software that allow robots and drones to truly understand the space around them.Spun out from Imperial College London, SLAMcore hascreated real-time, commercial grade, location, mapping and perception (SLAM) software for use in autonomous robots, drones and consumer products. The SLAMcore software enables fast prototyping and development of commercial products using visual SLAM software for autonomous location, mapping and perception. The software runs in real-time on standard compute/sensors and can be customised for commercial products using cost-effective custom compute/sensors. The team includes industry leading SLAM experts, roboticists, engineers and developers. Pushing the boundaries of what's possible today and how visual SLAM will look like tomorrow. Through partnership with OEMs, SLAMcore provides the core technology that allows robots to become a meaningful part of everyday life. | $14M |  | May 27, 2026 |  |
| Mantle8 | Mantle8 is a natural hydrogen exploration company. It has developed geological models and imaging technologies that detect the best natural hydrogen locations with “world-first accuracy“ | $36.4M | Series A | May 13, 2026 |  |
| Barocal | Barocal is a Zero-carbon refrigeration pioneer. | $10M | Seed | May 04, 2026 |  |
| Hypervision Surgical | Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging. | $23M | Series A | Apr 29, 2026 |  |
| Alesi Surgical | Alesi Surgical was founded in 2009 to develop and commercialise products that improve the safety, efficacy and outcomes of surgical procedures. The company is a spin-out from the Welsh Institute for Minimal Access Therapy (WIMAT), a leading surgical training centre in the UK. Alesi Surgical has a unique level of access to experiencedsurgeons, surgical trainers and trainees, which allows it to identify issues in procedures and design devices to address these issues. | $7M | Venture - Series Unknown | Apr 21, 2026 |  |
| First Light Fusion | First Light Fusion was spun out from the University of Oxford and focuses on researching energy generation by inertial confinement fusion. Its platform explores a number of alternative research directions that harness fundamental physics focusing on power generation and theoretical analysis, detailed numerical simulation, and experimentalvalidation that helps clients to discover a new source of energy. The company directly employs a team of engineers and physicists and collaborates closely with a number of academic organizations, including the University of Oxford, Warwick University, UCL, and Imperial College, London.The company was founded by Professor Yiannis Ventikos and Dr. Nicholas Hawker and is based in Yarnton, Oxfordshire. | $25M | Venture - Series Unknown | Apr 21, 2026 |  |
| Storm Therapeutics | Targeting pathways that modify RNA to deliver novel cancer therapeutics. | $56M | Series C | Apr 16, 2026 |  |
| Oxa | Oxa develops autonomous vehicle software and hardware solutions for industrial mobility automation. The company provides self-driving software that can be configured for various industrial vehicles, paired with modular hardware systems that allow existing fleets to be upgraded. Oxa also offers fleet management software that can integrate withthird-party logistics systems to support coordinated operations. Its solutions focus on improving efficiency, productivity, and safety in environments such as ports, airports, and industrial yards. Oxa incorporates safety and monitoring measures throughout its development and deployment processes, ensuring controlled and explainable vehicle autonomy. The company collaborates with organizations to implement and optimize automation strategies while supporting the adoption and operation of autonomous fleets. | $102.6M | Series D | Mar 04, 2026 |  |

10 of 206 investments shown.

## Co-investors
- [Parkwalk Advisors](https://shizune.co/investors/profile/parkwalk-advisors) — VC Fund, 32 deals together
- [Hostplus](https://shizune.co/investors/profile/hostplus) — VC Fund, 18 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 18 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-science-enterprises) — VC Fund, 13 deals together
- [Woodford Investment Management](https://shizune.co/investors/profile/woodford-investment-management) — VC Fund, 12 deals together
- [Lansdowne Partners](https://shizune.co/investors/profile/lansdowne-partners) — VC Fund, 9 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [All VC Funds in United Kingdom](https://shizune.co/investors/vc-funds-united-kingdom)
- [All Investors in United Kingdom](https://shizune.co/investors/investors-united-kingdom)
- [Transportation Investors in United Kingdom](https://shizune.co/investors/transportation-investors-united-kingdom)
- [Transportation VC Funds in United Kingdom](https://shizune.co/investors/transportation-vc-funds-united-kingdom)
- [Health Care Investors in United Kingdom](https://shizune.co/investors/health-care-investors-united-kingdom)
- [Health Care VC Funds in United Kingdom](https://shizune.co/investors/health-care-vc-funds-united-kingdom)

## FAQ

### What does IP Group invest in?

IP Group invests primarily in Health Care, Biotechnology and Therapeutics startups, most often at Seed and Series A stage. Most of the 206 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is IP Group's check size?

IP Group typically joins rounds of $393k–$8.5M at Seed and $2.4M–$30M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds IP Group participates in.

### How do I contact IP Group?

Public channels for IP Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at IP Group?

The team at IP Group includes Ben Murphey (Investment Director), Dani Bach (Partner, Life Sciences) and Greg Smith (Chief Financial Officer), among 23 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co